159 related articles for article (PubMed ID: 29371980)
1. Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy.
Paret C; Russo A; Otto H; Mayer A; Zahnreich S; Wagner W; Samuel D; Scharnhorst D; Solomon DA; Dhall G; Wong K; Bender H; Alt F; Wingerter A; Neu MA; Beck O; Prawitt D; Eder S; Henninger N; El Malki K; Lehmann N; Backes N; Roth L; Seidmann L; Sommer C; Brockmann MA; Staatz G; Schmidberger H; Faber J
Oncotarget; 2017 Dec; 8(69):114210-114225. PubMed ID: 29371980
[TBL] [Abstract][Full Text] [Related]
2. Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.
Paret C; Theruvath J; Russo A; Kron B; El Malki K; Lehmann N; Wingerter A; Neu MA; Gerhold-Ay A; Wagner W; Sommer C; Pietsch T; Seidmann L; Faber J
Oncotarget; 2016 Dec; 7(50):83378-83391. PubMed ID: 27825128
[TBL] [Abstract][Full Text] [Related]
3. IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients.
Vewinger N; Huprich S; Seidmann L; Russo A; Alt F; Bender H; Sommer C; Samuel D; Lehmann N; Backes N; Roth L; Harter PN; Filipski K; Faber J; Paret C
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234291
[TBL] [Abstract][Full Text] [Related]
4. HGNET-BCOR Tumors of the Cerebellum: Clinicopathologic and Molecular Characterization of 3 Cases.
Appay R; Macagno N; Padovani L; Korshunov A; Kool M; André N; Scavarda D; Pietsch T; Figarella-Branger D
Am J Surg Pathol; 2017 Sep; 41(9):1254-1260. PubMed ID: 28704208
[TBL] [Abstract][Full Text] [Related]
5. CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.
Yoshida Y; Nobusawa S; Nakata S; Nakada M; Arakawa Y; Mineharu Y; Sugita Y; Yoshioka T; Araki A; Sato Y; Takeshima H; Okada M; Nishi A; Yamazaki T; Kohashi K; Oda Y; Hirato J; Yokoo H
Brain Pathol; 2018 Sep; 28(5):710-720. PubMed ID: 29226988
[TBL] [Abstract][Full Text] [Related]
6. A single supratentorial high-grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival.
Bremer J; Kottke R; Johann PD; von Hoff K; Brazzola P; Grotzer MA; Kool M; Rushing E; Gerber NU
Pediatr Blood Cancer; 2020 Jul; 67(7):e28384. PubMed ID: 32383815
[TBL] [Abstract][Full Text] [Related]
7. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.
Ferris SP; Velazquez Vega J; Aboian M; Lee JC; Van Ziffle J; Onodera C; Grenert JP; Saunders T; Chen YY; Banerjee A; Kline CN; Gupta N; Raffel C; Samuel D; Ruiz-Diaz I; Magaki S; Wilson D; Neltner J; Al-Hajri Z; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Schniederjan M; Cha S; Perry A; Solomon DA
Brain Pathol; 2020 Jan; 30(1):46-62. PubMed ID: 31104347
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)-case-based reviews.
De Lima L; Sürme MB; Gessi M; Mastronuzzi A; Miele E; Tamburrini G; Massimi L
Childs Nerv Syst; 2020 Aug; 36(8):1589-1599. PubMed ID: 32542405
[TBL] [Abstract][Full Text] [Related]
9. Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes.
Łastowska M; Trubicka J; Sobocińska A; Wojtas B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Perek-Polnik M; Dembowska-Bagińska B; Grajkowska W; Matyja E
Acta Neuropathol Commun; 2020 Jul; 8(1):105. PubMed ID: 32650833
[TBL] [Abstract][Full Text] [Related]
10. Early Wound Site Seeding in a Patient with Central Nervous System High-Grade Neuroepithelial Tumor with BCOR Alteration.
Kirkman MA; Pickles JC; Fairchild AR; Avery A; Pietsch T; Jacques TS; Aquilina K
World Neurosurg; 2018 Aug; 116():279-284. PubMed ID: 29859355
[TBL] [Abstract][Full Text] [Related]
11. Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma.
Ally MS; Ransohoff K; Sarin K; Atwood SX; Rezaee M; Bailey-Healy I; Kim J; Beachy PA; Chang AL; Oro A; Tang JY; Colevas AD
JAMA Dermatol; 2016 Apr; 152(4):452-6. PubMed ID: 26765315
[TBL] [Abstract][Full Text] [Related]
12. Clinical, pathological, and molecular features of central nervous system tumors with BCOR internal tandem duplication.
Wang W; Zhang A; Li Y; Wang D; Chen L; Li Q; Chen J; Li H; Sun S; Pan M; Zhou W; Wu H
Pathol Res Pract; 2024 May; 259():155367. PubMed ID: 38797130
[TBL] [Abstract][Full Text] [Related]
13. Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.
Torre M; Meredith DM; Dubuc A; Solomon DA; Perry A; Vasudevaraja V; Serrano J; Snuderl M; Ligon KL; Alexandrescu S
J Neuropathol Exp Neurol; 2019 Apr; 78(4):305-314. PubMed ID: 30816933
[TBL] [Abstract][Full Text] [Related]
14. A Cerebellar High-Grade Neuroepithelial Tumour with BCOR Alteration in a five-year-old Child: A case report.
Al-Battashi A; Al Hajri Z; Perry A; Al-Kindi H; Al-Ghaithi I
Sultan Qaboos Univ Med J; 2019 May; 19(2):e153-e156. PubMed ID: 31538015
[TBL] [Abstract][Full Text] [Related]
15. Specific and Sensitive Diagnosis of
Barets D; Appay R; Heinisch M; Battistella M; Bouvier C; Chotard G; Le Loarer F; Macagno N; Perbet R; Pissaloux D; Rousseau A; Tauziède-Espariat A; Varlet P; Vasiljevic A; Colin C; Fina F; Figarella-Branger D
Front Oncol; 2021; 11():645512. PubMed ID: 33718245
[No Abstract] [Full Text] [Related]
16. CNS tumor with BCOR internal tandem duplication: Clinicopathologic, molecular characteristics and prognosis factors.
Wang R; Guan W; Qiao M; Zhang Y; Zhang M; Wang K; Wang Y; Wang L
Pathol Res Pract; 2022 Aug; 236():153995. PubMed ID: 35809497
[TBL] [Abstract][Full Text] [Related]
17. BCOR Positive Central Nervous System Neuroepithelial Tumor Masquerading as a Meningioma.
Ahuja S; Khan AA; Zaheer S
Indian J Surg Oncol; 2024 Jun; 15(2):359-363. PubMed ID: 38741634
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract][Full Text] [Related]
19. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
20. Characterization of arsenic trioxide resistant clones derived from Jurkat leukemia T cell line: focus on PI3K/Akt signaling pathway.
Roszak J; Smok-Pieniążek A; Nocuń M; Stępnik M
Chem Biol Interact; 2013 Oct; 205(3):198-211. PubMed ID: 23911876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
